Cadence Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-981
| Closed | -$229K | – | 421 |
|
|
2019
Q2 | $229K | Buy |
981
+31
| +3% | +$7.24K | 0.02% | 395 |
|
|
2019
Q1 | $225K | Buy |
950
+1
| +0.1% | +$237 | 0.02% | 428 |
|
|
2018
Q4 | $286K | Sell |
949
-5,150
| -84% | -$1.55M | 0.03% | 397 |
|
|
2018
Q3 | $2.16M | Sell |
6,099
-614
| -9% | -$217K | 0.12% | 243 |
|
|
2018
Q2 | $1.95M | Buy |
6,713
+81
| +1% | +$23.5K | 0.12% | 241 |
|
|
2018
Q1 | $1.82M | Buy |
6,632
+161
| +2% | +$44.1K | 0.12% | 219 |
|
|
2017
Q4 | $2.06M | Buy |
6,471
+54
| +0.8% | +$17.2K | 0.13% | 182 |
|
|
2017
Q3 | $2.01M | Sell |
6,417
-4,141
| -39% | -$1.3M | 0.13% | 189 |
|
|
2017
Q2 | $2.87M | Sell |
10,558
-1,178
| -10% | -$320K | 0.2% | 123 |
|
|
2017
Q1 | $3.21M | Buy |
11,736
+883
| +8% | +$241K | 0.22% | 111 |
|
|
2016
Q4 | $3.08M | Buy |
10,853
+361
| +3% | +$102K | 0.22% | 111 |
|
|
2016
Q3 | $3.28M | Buy |
10,492
+1,227
| +13% | +$384K | 0.24% | 108 |
|
|
2016
Q2 | $2.24M | Sell |
9,265
-75
| -0.8% | -$18.1K | 0.17% | 149 |
|
|
2016
Q1 | $2.43M | Buy |
9,340
+19
| +0.2% | +$4.95K | 0.17% | 142 |
|
|
2015
Q4 | $2.86M | Sell |
9,321
-440
| -5% | -$135K | 0.19% | 140 |
|
|
2015
Q3 | $2.85M | Buy |
9,761
+2,547
| +35% | +$743K | 0.2% | 128 |
|
|
2015
Q2 | $2.91M | Sell |
7,214
-77
| -1% | -$31.1K | 0.16% | 159 |
|
|
2015
Q1 | $3.08M | Sell |
7,291
-329
| -4% | -$139K | 0.19% | 147 |
|
|
2014
Q4 | $2.59M | Buy |
+7,620
| New | +$2.59M | 0.15% | 185 |
|